115 related articles for article (PubMed ID: 6540221)
1. Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix.
Piver MS; Barlow JJ; Lele SB; Maniccia M
Gynecol Oncol; 1984 Jul; 18(3):313-9. PubMed ID: 6540221
[TBL] [Abstract][Full Text] [Related]
2. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Lele SB; Piver MS
Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
4. Methyl-CCNU, doxorubicin, and cis-diamminedichloroplatinum II in the management of recurrent and metastatic squamous carcinoma of the cervix.
Carlson JA; Day TG; Allegra JC; Woodcock TM; Greenberg RA; Masterson BJ
Cancer; 1984 Jul; 54(2):211-4. PubMed ID: 6539161
[TBL] [Abstract][Full Text] [Related]
5. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Thigpen T; Shingleton H; Homesley H; Lagasse L; Blessing J
Cancer; 1981 Aug; 48(4):899-903. PubMed ID: 7196794
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
Vogl SE; Seltzer V; Camacho F; Davis TE
J Reprod Med; 1986 May; 31(5):327-9. PubMed ID: 2427717
[No Abstract] [Full Text] [Related]
7. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma.
Malfetano J; Keys H; Kredentser D; Cunningham M; Kotlove D; Weiss L
Cancer; 1993 Jun; 71(11):3703-6. PubMed ID: 8387884
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma.
Tamura K; Araki Y; Tateyama H; Maeda M; Seita M
J Surg Oncol; 1987 Aug; 35(4):241-4. PubMed ID: 2441207
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix.
Tebbutt N; Rischin D; Quinn M; Rome R; Millward MJ; Toner GC; Bishop JF
Aust N Z J Obstet Gynaecol; 1998 Feb; 38(1):87-90. PubMed ID: 9521400
[TBL] [Abstract][Full Text] [Related]
11. Cis-diamminedichloroplatinum (II): second line induction chemotherapy in advanced ovarian adenocarcinoma.
Piver MS; Barlow JJ; Lele SB; Malfetano JH; McPhee ME
J Surg Oncol; 1983 Dec; 24(4):329-31. PubMed ID: 6418977
[TBL] [Abstract][Full Text] [Related]
12. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
Senapad S; Neungton S; Usavajindawath C; Vijatrasil S; Thaithanaisawanya V
J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
Rotmensch J; Senekjian EK; Javaheri G; Herbst AL
Gynecol Oncol; 1988 Jan; 29(1):76-81. PubMed ID: 3338666
[TBL] [Abstract][Full Text] [Related]
14. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy in recurrent and advanced cervical cancer.
Kumar L; Bhargava VL
Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer.
Murata S; Onozawa S; Sugihara F; Sakamoto A; Ueda T; Yamaguchi H; Yasui D; Mine T; Kumita S
Ann Surg Oncol; 2015 Nov; 22(12):3981-9. PubMed ID: 25758191
[TBL] [Abstract][Full Text] [Related]
17. Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance.
Chumworathayi B; Suprasert P; Charoenkwan K; Srisomboon J; Phongnarisorn C; Siriaree S; Cheewakriangkrai C; Tantipalakorn J; Kiatpeerakul C; Pantusart A
J Med Assoc Thai; 2005 Nov; 88(11):1483-92. PubMed ID: 16471090
[TBL] [Abstract][Full Text] [Related]
18. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
19. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
Wheelock JB; Krebs HB; Goplerud DR; Myers M
Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
[TBL] [Abstract][Full Text] [Related]
20. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
